Short interest in Achilles Therapeutics PLC (NASDAQ:ACHL) decreased during the last reporting period, falling from 212.55K to 159.25K. This put 0.59% of the company's publicly available shares short.

Short interest for Achilles Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Achilles Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 70.63K shares traded per day, it would take 2.25 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.